Teva Pharmaceutical Industries
TEVA
#654
Rank
NZ$68.53 B
Marketcap
NZ$58.86
Share price
-1.22%
Change (1 day)
112.96%
Change (1 year)

EPS for Teva Pharmaceutical Industries (TEVA)

EPS in 2026 (TTM): NZ$2.35

According to Teva Pharmaceutical Industries's latest financial reports the company's current EPS (TTM) is NZ$2.43. In 2025 the company made an earnings per share (EPS) of NZ$2.20 an increase over its 2024 EPS that were of NZ-$2.57.

EPS history for Teva Pharmaceutical Industries from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.356.8%
2025NZ$2.20-185.52%
2024NZ-$2.57208.51%
2023NZ-$0.83-77.83%
2022NZ-$3.76-657.89%
2021NZ$0.67
2019NZ-$1.63-60.34%
2018NZ-$4.11-85.73%
2017NZ-$28.82-23328.57%
2016NZ$0.12-96.2%
2015NZ$3.26-48.6%
2014NZ$6.34138.67%
2013NZ$2.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.44 412.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-4.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.54 86.84%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.30 159.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.32 407.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.89 183.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
NZ$1.33-45.06%๐Ÿ‡ฎ๐Ÿ‡ณ India